Search

everythinglearnresearchcommunity

for

Search:↓

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Olorofim effectively treats fungal skin infections.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Compound 4 is a promising treatment for hair loss with low toxicity.

The new compound may be a safer alternative to finasteride for prostate protection.

Baricitinib works better than methotrexate for severe alopecia areata.

Certain amino acid analogues can inhibit wool and hair growth and affect fiber strength.

Clofazimine effectively treated ashy dermatosis in a patient.

Methotrexate is not proven to maintain remission in ulcerative colitis.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

New progesterone-based compounds can block male hormones.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.